| # | Drug | Count |
|---|---|---|
| 0 | BRIVARACETAM | 4 |
| 1 | BRIVARACETAM INJECTION | 4 |
| 2 | ETHOSUXIMIDE | 4 |
| 3 | ATEZOLIZUMAB | 2 |
| 4 | BEVACIZUMAB | 2 |
| 5 | CARBOPLATIN | 2 |
| 6 | NIVOLUMAB | 2 |
| 7 | PACLITAXEL | 2 |
| 8 | PACLITAXEL (AIBUMIN-BOUND) | 2 |
| 9 | AMLODIPINE BESYLATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETHOSUXIMIDE | 4 | 0.0016 |
| 1 | RILONACEPT | 1 | 0.0009 |
| 2 | BRIVARACETAM | 4 | 0.0004 |
| 3 | APREPITANT | 1 | 0.0001 |
| 4 | VONOPRAZAN FUMARATE | 1 | 0.0001 |
| 5 | ZONISAMIDE | 1 | 0.0001 |
| 6 | FOSAPREPITANT DIMEGLUMINE | 1 | 0.0001 |
| 7 | CLOBAZAM | 1 | 0.0001 |
| 8 | RIVASTIGMINE | 1 | 0.0001 |
| 9 | ATEZOLIZUMAB | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 1 | Cholinesterase Inhibitor [EPC] | 1 | 0.0001 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 5 | 0.0001 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Anti-epileptic Agent [EPC] | 4 | 0.0000 |
| 5 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 8 | P2Y12 Platelet Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 2 | 0.0000 |